EPOCH EPIGENETICS
LIVE

Serial Number

99908001

Owner

EPOCH Epigenetics, Inc.

Attorney

John Paul Oleksiuk

Filing Date

Jun 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

EPOCH EPIGENETICS Trademark

Serial Number: 99908001

EPOCH EPIGENETICS is a trademark filed by EPOCH Epigenetics, Inc. on June 26, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

EPOCH Epigenetics, Inc.

4 N Martin Luther King Jr Blvd.
Baltimore, MD 21201

Entity Type: 03

Trademark Details

Filing Date

June 26, 2026

Registration Date

Not Registered

Goods & Services

Medical research; Scientific research; Genetic testing for scientific research purposes; Medical and scientific research in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive disease, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical and scientific research in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Research laboratory analysis services in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Blood testing for scientific research purposes

Medical screening; Medical testing services; Genetic testing for medical purposes; Medical screening services in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive disease, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical testing for diagnostic or treatment purposes in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening services in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical testing services of blood serums

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 26, 2026 MAFR
NEW APPLICATION ENTERED
Jun 26, 2026 NWAP